• A study to evaluate the safety and effectiveness of KPL-387 in patients with well-controlled recurrent pericarditis

    Recruiting

    2 1 1
    France Germany Greece Italy Poland Spain

  • A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Croatia Czechia Denmark France +10

  • A study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Italy +5

  • A long-term safety study of KYV-101 in patients previously treated for lupus nephritis, systemic sclerosis, myasthenia gravis, rheumatoid arthritis, or stiff person syndrome

    Recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • A study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +7

  • A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn’s disease

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia France Germany +9

  • A study of finerenone added to standard treatment in children aged 6 months to under 18 years with heart failure and reduced left heart pumping function

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Finland Germany +7

  • A Study of Camizestrant and Ribociclib for Patients with Hormone Receptor-Positive Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain

  • A Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria France Germany Italy The Netherlands Poland +1

  • A study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy

    Recruiting

    3 1
    Investigated Diseases:
    Belgium Czechia Denmark France Germany Italy +2

powered by